The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 3 , Pages 565-573 , September 2007

Bone marrow–derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site

  • Jussi Mäkelä, BM

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Kari Ylitalo, MD, PhD

      Affiliations

    • Department of Cardiology, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Siri Lehtonen, PhD

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Sebastian Dahlbacka, MD

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Eija Niemelä, BM

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Kai Kiviluoma, MD, PhD

      Affiliations

    • Department of Anaesthesiology, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
  • ,
  • Jussi Rimpiläinen, MD, PhD

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Hanna Alaoja, BM

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Timo Paavonen, MD, PhD

      Affiliations

    • Department of Pathology, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
  • ,
  • Petri Lehenkari, MD, PhD

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
    • Drs Lehenkari, Juvonen, and Anttila all contributed equally to this study.
  • ,
  • Tatu Juvonen, MD, PhD

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
    • Drs Lehenkari, Juvonen, and Anttila all contributed equally to this study.
    • Corresponding Author InformationAddress for reprints: Professor Tatu Juvonen, Department of Surgery, Oulu University Hospital, PO Box 21, 90029 Oulu, Finland.
  • ,
  • Vesa Anttila, MD, PhD

      Affiliations

    • Department of Surgery, Clinical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland
    • Drs Lehenkari, Juvonen, and Anttila all contributed equally to this study.

Received 25 February 2007 ,Revised 18 April 2007 ,Accepted 2 May 2007.

  • Image Result

    Bone marrow–derived mononuclear cell (BMMC) injection at the infarction site enables ejection fraction recovery. The ejection fraction decreased after infarction critically (>15%) in both groups (!P =

    Bone marrow–derived mononuclear cell (BMMC) injection at the infarction site enables ejection fraction recovery. The ejection fraction decreased after infarction critically (>15%) in both groups (!P = .03). After the 3-week recovery period, the ejection fraction increased significantly in the BMMC group (*P = .02) but remained at the same decreased level in the control group. Data points represent actual median values ± standard deviation.

  • Image Result
    Injected DiI-labeled cells remain at the infarct site. Transplanted DiI-labeled (white arrows) cells were detected by using a fluorescent microscope (magnification ×20) from the infarcted area (A) and

    Injected DiI-labeled cells remain at the infarct site. Transplanted DiI-labeled (white arrows) cells were detected by using a fluorescent microscope (magnification ×20) from the infarcted area (A) and from some of the perihilar lymph nodes (B). A sample from undamaged heart muscle was negative (C), as were samples from the liver (D), spleen (E), and lungs (F). Bars = 100 μm.

  • Image Result
    Injected DiI-labeled cells differentiate at the injection site. DiI-positive cells in the granulation tissue area at the infarcted myocardium showed positive expression of α-smooth muscle actin (α-SMA

    Injected DiI-labeled cells differentiate at the injection site. DiI-positive cells in the granulation tissue area at the infarcted myocardium showed positive expression of α-smooth muscle actin (α-SMA; A and B), Ki-67 (C and D; magnification ×20), vimentin (E and F; magnification ×40), and muscle-specific actin (MSA; G and H; magnification ×60). Bars = 20 μm.

  • Image Result
    Injection of bone marrow–derived mononuclear cells (BMMC) enhances cell survival and recruitment at the infarction site parenchyma. Larger quantities of living cells in the necrotic area were observed

    Injection of bone marrow–derived mononuclear cells (BMMC) enhances cell survival and recruitment at the infarction site parenchyma. Larger quantities of living cells in the necrotic area were observed with a fluorescent microscope (magnification ×20) in the BMMC group by using Hoechst staining (A and B) compared with the control group (E and F). In cell counting a significant difference between the groups could readily be observed (I; ***P < .001). Similarly, a larger number of Stro-1–positive cells was detected in the BMMC group (C, D, and J; P < .001) compared with the control group (G and H). The highest density of Stro-1–positive cells was detected at the vessel walls in the BMMC group (D) in contrast to the control group (H). Bars in A, C, E, and G = 100 μm; bars in B, D, F, and H = 20 μm.

  • Image Result
    Injection of bone marrow–derived mononuclear cells (BMMC) promotes postinfarction remodeling. Analysis of the immunohistologic staining with a light microscope revealed differences between the control

    Injection of bone marrow–derived mononuclear cells (BMMC) promotes postinfarction remodeling. Analysis of the immunohistologic staining with a light microscope revealed differences between the control and BMMC groups (images with ×10 magnification are shown). Enhanced vimentin staining (A and C), indicating a larger quantity of mesenchymal cells in the necrotic area (E; P < .01) and in the border zone (F; P < .001), could be seen in the BMMC group. For the muscle actin staining (B and D), the proportional area of cell coverage was greater in the granulation tissue area (G) in the BMMC group (P = .035). Bars = 50 μm.

 The study was supported by the Finnish Heart Research Foundation.

PII: S0022-5223(07)00770-2

doi: 10.1016/j.jtcvs.2007.05.004

The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 3 , Pages 565-573 , September 2007